Table 1.
Capripoxvirus strain DNA used in the study
| Sample | Mean Ct ± SD |
|---|---|
| LSDV Russia, 2015 | 29.99 ± 0.27 |
| LSDV Russia, 2016 | 30.75 ± 0.45 |
| LSDV Russia, 2017 | 31.55 ± 0.36 |
| LSDV Abkhazia, 2017 | 31.76 ± 0.41 |
| LSDV Kazakhstan, 2016 | 32.81 ± 0.49 |
| LSDV Ethiopia, 1995 | 24.16 ± 0.11 |
| LSDV unknown origin and year | 25.8 ± 0.27 |
| LSDV Massalamia | 32.21 ± 0.21 |
| LSDV Bulgaria* | 33.85 ± 0.34 |
| vaccine LSDV Onderspoort vaccine strain | 29.17 ± 0.19 |
| LSDV Lumpyvax | 30.55 ± 0.35 |
| Neethling LSDV * | 30.01 ± 0.11 |
| vaccine-like LSDV Russia, 2017 | 29.39 ± 0.12 |
| vaccine-like LSDV Russia, 2017 | 31.00 ± 0.24 |
| vaccine-like LSDV Russia, 2017 | 31.55 ± 0.39 |
| recombinant LSDV strain, 2017 | 29.99 ± 0.28 |
| SPPV Afghanistan, 2003 | no Ct |
| SPPV Russia, 2015 | no Ct |
| SPPV Russia, 2016 | no Ct |
| SSPV Niskhi | no Ct |
| SSPV Morocco | no Ct |
| SPPV Arbel* | no Ct |
| SSPV (unknown origin)* | no Ct |
| GTPV Russia, 2003 | no Ct |
| GTPV Gorgan | no Ct |
| GTPV Oman | no Ct |
*Positive samples were supplied by Sciensano (Belgium)